Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Tumour heterogeneity in the clinic
Abstract CT190: A Phase II basket study of hypomethylating agent oral cc-486 and durvalumab in advanced solid tumors (METADUR)
